These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10549028)

  • 1. [Transdermal Phentanyl. New therapeutic option in chronic non-tumor-induced pain].
    Orthopade; 1999 Sep; 28(9 Suppl):1-4. PubMed ID: 10549028
    [No Abstract]   [Full Text] [Related]  

  • 2. Transdermal fentanyl: new preparation. An alternative to morphine.
    Prescrire Int; 1998 Oct; 7(37):137-40. PubMed ID: 10915416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of pain management: agents used for somatic pain.
    Saunders P; Gannon R;
    Conn Med; 2005 Mar; 69(3):147-9. PubMed ID: 15862001
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fentanyl by buccal administration. Fifty to hundred times stronger than morphine against pain].
    Taeron C
    Rev Infirm; 2002 Sep; (83):47-9. PubMed ID: 12380268
    [No Abstract]   [Full Text] [Related]  

  • 6. Tramadol and strong opioid: synergistic or additive opioid effect?
    Di Lorenzo L
    Pain Pract; 2008; 8(3):214-5; author reply 215-6. PubMed ID: 18476900
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies of the analgesic activity of transamine and its combination with phentanyl].
    Siluianova EV; Gur'ianov VA; Aliautdin RN; Petrov VE; Tiukov VA
    Anesteziol Reanimatol; 2005; (3):60-1. PubMed ID: 16076051
    [No Abstract]   [Full Text] [Related]  

  • 9. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid therapy for chronic painful conditions.
    Burgess FW
    Med Health R I; 2001 Oct; 84(10):323-6. PubMed ID: 11693049
    [No Abstract]   [Full Text] [Related]  

  • 12. Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
    Heidemann AJ; Seaton TL
    J Fam Pract; 2001 Oct; 50(10):897. PubMed ID: 11674896
    [No Abstract]   [Full Text] [Related]  

  • 13. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.
    Greiner W; Lehmann K; Earnshaw S; Bug C; Sabatowski R
    Eur J Health Econ; 2006 Dec; 7(4):290-6. PubMed ID: 16983521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain.
    Imai S; Narita M; Hashimoto S; Nakamura A; Miyoshi K; Nozaki H; Hareyama N; Takagi T; Suzuki M; Narita M; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):183-92. PubMed ID: 17240843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fentanyl patch for stable chronic pain in children: new indication. Used fentanyl patches should be handled with care.
    Prescrire Int; 2008 Jun; 17(95):104. PubMed ID: 18623912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
    Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
    Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of transdermal fentanyl in chronic non-malignant pain].
    Akkaya T; Sayin M; Gümüş H
    Agri; 2005 Jan; 17(1):39-44. PubMed ID: 15791499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
    Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
    Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.